93 related articles for article (PubMed ID: 21071471)
1. The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis.
Guilpain P; Chéreau C; Goulvestre C; Servettaz A; Montani D; Tamas N; Pagnoux C; Hachulla E; Weill B; Guillevin L; Mouthon L; Batteux F
Eur Respir J; 2011 Jun; 37(6):1503-13. PubMed ID: 21071471
[TBL] [Abstract][Full Text] [Related]
2. Impact of MPO-ANCA-mediated oxidative imbalance on renal vasculitis.
Hilhorst M; Maria AT; Kavian N; Batteux F; Borderie D; Le Quellec A; van Paassen P; Guilpain P
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1769-F1776. PubMed ID: 30207165
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic effects of antimyeloperoxidase antibodies in patients with microscopic polyangiitis.
Guilpain P; Servettaz A; Goulvestre C; Barrieu S; Borderie D; Chéreau C; Kavian N; Pagnoux C; Guillevin L; Weill B; Mouthon L; Batteux F
Arthritis Rheum; 2007 Jul; 56(7):2455-63. PubMed ID: 17599755
[TBL] [Abstract][Full Text] [Related]
4. [Inhibition of oxidative activity of myeloperoxidase by anti-myeloperoxidase antibodies from patients with microscopic polyangiitis].
Chen J; Chen M; Liu Zs; Zhao Mh
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Apr; 40(2):155-9. PubMed ID: 18458690
[TBL] [Abstract][Full Text] [Related]
5. Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies.
Guilpain P; Servettaz A; Batteux F; Guillevin L; Mouthon L
Autoimmun Rev; 2008 Jun; 7(6):421-5. PubMed ID: 18558355
[TBL] [Abstract][Full Text] [Related]
6. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse.
Servettaz A; Goulvestre C; Kavian N; Nicco C; Guilpain P; Chéreau C; Vuiblet V; Guillevin L; Mouthon L; Weill B; Batteux F
J Immunol; 2009 May; 182(9):5855-64. PubMed ID: 19380834
[TBL] [Abstract][Full Text] [Related]
7. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
8. Comparison of characteristics of natural autoantibodies against myeloperoxidase and anti-myeloperoxidase autoantibodies from patients with microscopic polyangiitis.
Xu PC; Cui Z; Chen M; Hellmark T; Zhao MH
Rheumatology (Oxford); 2011 Jul; 50(7):1236-43. PubMed ID: 21372002
[TBL] [Abstract][Full Text] [Related]
9. Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis.
Xu PC; Chen M; Cui Z; Zhao MH
Rheumatology (Oxford); 2010 Nov; 49(11):2068-75. PubMed ID: 20675709
[TBL] [Abstract][Full Text] [Related]
10. Increased concentrations of antibody against heat shock protein in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody positive microscopic polyangiitis.
Komiya I; Arimura Y; Nakabayashi K; Yamada A; Osaki T; Yamaguchi H; Kamiya S
Microbiol Immunol; 2011 Aug; 55(8):531-8. PubMed ID: 21605158
[TBL] [Abstract][Full Text] [Related]
11. IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.
Liu LJ; Chen M; Yu F; Zhao MH; Wang HY
Nephrology (Carlton); 2008 Oct; 13(7):629-35. PubMed ID: 18775059
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of oxidation activity of myeloperoxidase (MPO) by propylthiouracil (PTU) and anti-MPO antibodies from patients with PTU-induced vasculitis.
Zhang AH; Chen M; Gao Y; Zhao MH; Wang HY
Clin Immunol; 2007 Feb; 122(2):187-93. PubMed ID: 17070108
[TBL] [Abstract][Full Text] [Related]
13. Radical oxygen species production induced by advanced oxidation protein products predicts clinical evolution and response to treatment in systemic sclerosis.
Servettaz A; Guilpain P; Goulvestre C; Chéreau C; Hercend C; Nicco C; Guillevin L; Weill B; Mouthon L; Batteux F
Ann Rheum Dis; 2007 Sep; 66(9):1202-9. PubMed ID: 17363403
[TBL] [Abstract][Full Text] [Related]
14. Investigation of protein oxidation and lipid peroxidation in patients with rheumatoid arthritis.
Baskol G; Demir H; Baskol M; Kilic E; Ates F; Karakukcu C; Ustdal M
Cell Biochem Funct; 2006; 24(4):307-11. PubMed ID: 16142689
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
Morgan PE; Sturgess AD; Davies MJ
Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
[TBL] [Abstract][Full Text] [Related]
16. Protein oxidation status in patients with ankylosing spondylitis.
Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and spectrophotometric significance of advanced oxidized protein products.
Capeillère-Blandin C; Gausson V; Descamps-Latscha B; Witko-Sarsat V
Biochim Biophys Acta; 2004 Jun; 1689(2):91-102. PubMed ID: 15196590
[TBL] [Abstract][Full Text] [Related]
18. Advanced Oxidation Protein Products-Modified Albumin Induces Differentiation of RAW264.7 Macrophages into Dendritic-Like Cells Which Is Modulated by Cell Surface Thiols.
Garibaldi S; Barisione C; Marengo B; Ameri P; Brunelli C; Balbi M; Ghigliotti G
Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075404
[TBL] [Abstract][Full Text] [Related]
19. Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
Kawakami T; Takeuchi S; Arimura Y; Soma Y
Br J Dermatol; 2012 Jun; 166(6):1206-12. PubMed ID: 22309950
[TBL] [Abstract][Full Text] [Related]
20. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody.
Liu B; Hou X; Zhou Q; Tian J; Zhu P; Xu J; Hou F; Fu N
Free Radic Res; 2011 Jun; 45(6):662-71. PubMed ID: 21391896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
